retatrutide triple hormone receptor agonist Retatrutide, an investigational that shows promise for weight loss in ongoing phase-3 clinical trials, is being sold openly across the internet and prescribed by licensed physicians online and Retatrutide Triple–Hormone-Receptor Agonist causes average

At higher doses of retatrutide (8mg and 12mg), side effects became more common, but were still rated as mild to moderate

Boosts energy levels: Additionally, glutathione reduces cell damage

(2021) found that after AS-II intervention in the kidneys of DKD rats, there was an increase in autophagy bodies of podocytes and PINK1, Parkin, Fist1 (a protein that binds to the Drp1 protein on the outer mitochondrial membrane to jointly regulate mitochondrial division), MFN2, LC3, mitochondrial outer membrane translocase 20 (TOMM20), and Nrf2 protein expression

The specific consequences depend on how far beyond the expiration the medication is used and the storage conditions maintained